Intellia Therapeutics, Inc. logo

Senior Principal Biostatistician

Intellia Therapeutics, Inc.

Cambridge, MARemotePosted 2 days ago$159,769.00 - $195,273.00/year
Full TimeSenior LevelBioinformatics & Data ScienceBiotechnology
Original posting ↗

Summary

The Senior Principal Biostatistician is responsible for leading the statistical activities for one or more clinical studies as part of a cross-functional team.

Job description

How You Will Achieve More

The Senior Principal Biostatistician is responsible for leading the statistical activities for one or more clinical studies as part of a cross-functional team.

Responsibilities

  • Authors/reviews study biostatistics documents (e.g., clinical study protocols, statistical analysis plans, mock Tables, Listings, and Figures shells).
  • Develops and reviews specifications for TLFs and provide statistical input into study-related analyses, publications, posters, and presentations.
  • Collaborates with cross-functional team members throughout study planning, conduct, analysis, and reporting to align deliverables and proactively resolve statistical and data-related issues.
  • Ensures deliverables are completed in a timely delivery and with high quality.
  • Contributes to study design including study endpoint and estimand selection, sample size and power calculations and analysis methods to ensure scientifically sound, and efficient and clearly interpretable results.
  • Contributes to interactions with external review boards/ethics committees and other external parties.
  • Collaborates with other line functions. Explain statistical concepts in an easily understandable way to non-statisticians and provide adequate statistical justifications for positions.
  • Remains apprised of current/new developments and technological advancements in statistics.

About You

  • Knowledge in scientific computing/programming (SAS, R or Python), data manipulation, graphing, and simulation.
  • Ability to develop innovative statistical solutions to problems.
  • Ability to identify data or analytical issues and assist with providing solutions by either applying own skills and knowledge or consulting with subject matter experts.
  • Good knowledge of early phase clinical trial designs and study conduct in relevant therapeutic areas.
  • Understanding of ICH GCP as well as general knowledge of industry practices and standards.
  • Able to build strong relationships with peers and cross-functional partners to achieve higher performance.
  • Demonstrate excellent collaboration, organizational/leadership abilities, and interpersonal skills with the ability to clearly explain statistical considerations to non-statisticians.
  • PhD or MS in Statistics or related field.
  • At least 3 years (PhD) or 6 years (MS) of experience in the Pharmaceutical/Biotechnology industry.
  • Prolonged periods of sitting at a desk and working on a computer.
  • Must be able to lift up to 15 pounds at times.

Requirements

  • Knowledge in scientific computing/programming (SAS, R or Python), data manipulation, graphing, and simulation
  • Ability to develop innovative statistical solutions to problems
  • Ability to identify data or analytical issues and assist with providing solutions
  • Good knowledge of early phase clinical trial designs and study conduct in relevant therapeutic areas
  • Understanding of ICH GCP as well as general knowledge of industry practices and standards
  • Able to build strong relationships with peers and cross-functional partners
  • Excellent collaboration, organizational/leadership abilities, and interpersonal skills
  • Ability to clearly explain statistical considerations to non-statisticians
  • PhD or MS in Statistics or related field
  • At least 3 years (PhD) or 6 years (MS) of experience in the Pharmaceutical/Biotechnology industry

Benefits

  • Performance-based annual cash bonus
  • New hire equity grant
  • Annual equity awards

Company overview

Intellia Therapeutics, Inc. is a leading clinical-stage biotechnology company focused on revolutionizing medicine through CRISPR-based gene editing therapies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company leverages Nobel Prize-winning CRISPR/Cas9 technology to develop potentially curative treatments for severe genetic diseases. Intellia operates with a dual approach: in vivo programs that use intravenously administered CRISPR to edit disease-causing genes directly within the body, and ex vivo programs that engineer human cells outside the body to treat cancer and autoimmune diseases. The company's pipeline includes advanced clinical programs for hereditary angioedema (NTLA-2002) and transthyretin amyloidosis (NTLA-2001), both in late-stage clinical trials. Intellia has established strategic collaborations with major pharmaceutical companies including Regeneron and Novartis, and maintains a strong intellectual property portfolio with over 400 patent documents. As a publicly traded company (NASDAQ: NTLA) with approximately 500-1,000 employees, Intellia represents a pioneering force in the gene editing space, working to transform the treatment paradigm for patients with serious genetic disorders through one-time, potentially curative therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.